Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine for Knee Osteoarthritis
NCT02176460Phase 3Completed
- Sponsor
- Singapore General Hospital
- Start
- Oct 2013
- Primary completion
- Sep 2015
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of colchicine in knee osteoarthritis (OA), sponsored by Singapore General Hospital. Started Oct 2013; status: completed.
02
Drugs
colchicine
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT02176460.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02176460.